Company: PSTV
Filing Date: 2025-07-11
Form Type: PRE 14A
Source: 0001140361-25-025650
Chunk: 59

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-07-11
Form: PRE 14A
Chunk 59
---
 at our sole election and in our discretion, subject to the terms and satisfaction of the conditions contained in the Lincoln Park Purchase Agreement. Required Vote The affirmative vote of a majority of the Common Stock having voting power present at the Annual Meeting or represented by proxy at the Annual Meeting is required to approve this proposal. Abstentions will be counted as present for purposes of determining a quorum and are considered shares present and entitled to vote and thus will have the effect of a vote “AGAINST” this proposal. OUR BOARD UNANIMOUSLY RECOMMENDS THAT THE STOCKHOLDERS VOTE “FOR” THE APPROVAL OF THE POTENTIAL ISSUANCE OF (I) UP TO $50 MILLION OF OUR ISSUED AND OUTSTANDING COMMON STOCK AND (II) UP TO $1 MILLION OF COMMITMENT SHARES, PURSUANT TO THE LINCOLN PARK PURCHASE AGREEMENT. The Lincoln Park Purchase Agreement Under the terms and subject to the conditions of the Lincoln Park Purchase Agreement, we have the right, but not the obligation, to sell to Lincoln Park, and Lincoln Park is obligated to purchase, up to $50.0 million of shares of Common Stock. Such sales of Common Stock by us, if any, are subject to certain limitations, and may occur from time to time, at our sole discretion, over the 36-month period (the “Commitment Period”) commencing after the satisfaction of certain conditions set forth in the Lincoln Park Purchase Agreement, including the effectiveness of a registration statement that we filed with the SEC in accordance with the terms of the Registration Rights Agreement, pursuant to which we have registered for resale by Lincoln Park 17,000,000 shares of Common Stock that we may issue and sell under the Lincoln Park Purchase Agreement. The Commitment Period began on June 23, 2025. Under the Lincoln Park Purchase Agreement, for a period of up to 36-months following the date on which all applicable conditions have been satisfied, on any business day that we select on which the closing sale price of our common stock equals or exceeds $0.10 per share, we may direct Lincoln Park to purchase up to 300,000 shares of our Common Stock in a “Regular Purchase” on such business day; provided, however, that (i) the Regular Purchase may be increased to up to 400,000 shares of our Common Stock if the closing sale price of our Common Stock is not below $0.50 on the purchase date, and (ii) the Regular Purchase may be